Sheffield Pharmaceuticals LLC

Form 483 issued March 15, 2019 · New London, Connecticut

Inspection
Mar 11 – Mar 15, 2019
Investigator
Maryam Tabatabaie
Observations
7
Pages
5
FEI number
1210513

In short: On March 15, 2019, FDA issued a Form 483 with 7 observations to Sheffield Pharmaceuticals LLC in New London, Connecticut (FEI 1210513) after an inspection that ran Mar 11 – Mar 15, 2019. The investigator was Maryam Tabatabaie. Most observations concern cAPA and production & process controls.

At a glance

CAPA and production & process controls account for 5 of 7 observations.

CAPA3
Production & process controls2
Design controls1
Records & documents1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures for design change have…

  2. 02

    Procedures for corrective and preventive action have…

  3. 03

    Procedures that define the responsibility for review and the authority for the disposition of nonconforming product…

  4. 04

    Procedures to ensure equipment is routinely calibrated have…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Sheffield Pharmaceuticals LLC?

FDA listed 7 observations on this Form 483, mostly about cAPA, production & process controls and design controls. The opening words of each observation are shown on this page.

Who inspected Sheffield Pharmaceuticals LLC?

Maryam Tabatabaie is named on this Form 483, for the inspection of Mar 11 – Mar 15, 2019. Each investigator has a profile showing what they cite most.

When was Sheffield Pharmaceuticals LLC inspected by FDA?

The inspection ran Mar 11 – Mar 15, 2019, and the Form 483 is dated March 15, 2019.

How do I get the full Form 483 for Sheffield Pharmaceuticals LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free